Sonavex: Funding, Investors & Team (Oct 2026)
Sonavex, Inc. is a Baltimore-based medical device company originally spun out of Johns Hopkins focused on Empowered Patient Care. The company has developed a portfolio of novel ultrasound solutions that empower patient care by delivering critical visual and quantitative data to improve outcomes and reduce costs. EchoMark is a bioresorbable and highly echogenic (visible under ultrasound) implant used to mark at-risk blood vessels such that the site can be easily assessed for future complications. EchoSure is a deep-learning enabled 3D automated ultrasound device designed to be used by healthcare providers without ultrasound training to assess blood flow and morphology of vessels marked by the implanted EchoMark device. For more information, please visit http://www.sonavex.com
Sonavex has raised $18.1M across 2 funding rounds on record, the most recent an undisclosed round of $3.1M announced in Jul 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Sonavex Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Sonavex Funding Rounds
Sonavex raised $15.0M in a Series A announced in Oct 2024.
1.8 years later, an undisclosed round of $3.1M was announced in Jul 2026.
Sonavex Investors
21 investors are recorded in total; the 5 named above are those the record identifies.
Sonavex Founders and Leadership Team
Contact details for the Sonavex team: 2 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Sonavex Funding Compared to Other Biotechnology Startups
Sonavex's latest round of $3.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sonavex in Biotechnology and Baltimore
Companies Similar to Sonavex
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Sonavex Funding FAQs
What does Sonavex do?
Sonavex, Inc. is a Baltimore-based medical device company originally spun out of Johns Hopkins focused on Empowered Patient Care. The company has developed a portfolio of novel ultrasound solutions that empower patient care by delivering critical visual and quantitative data to improve outcomes and reduce costs. EchoMark is a bioresorbable and highly echogenic (visible under ultrasound) implant used to mark at-risk blood vessels such that the site can be easily assessed for future complications. EchoSure is a deep-learning enabled 3D automated ultrasound device designed to be used by healthcare providers without ultrasound training to assess blood flow and morphology of vessels marked by the implanted EchoMark device. For more information, please visit http://www.sonavex.com
How much funding has Sonavex raised?
Sonavex has raised $18.1M across 2 rounds on record. The most recent is an undisclosed round of $3.1M announced in Jul 2026.
When did Sonavex last raise funding?
Sonavex's most recent funding round on record is an undisclosed round of $3.1M, announced in Jul 2026.
Who has invested in Sonavex?
Investors on record for Sonavex include TEDCO, Gaingels, Fusion Fund, National Science Foundation, Partners Capital. FundedIQ records 21 investors in total.
Who founded Sonavex?
FundedIQ lists Jerry Prince (Founder) at Sonavex.
Who is the CEO of Sonavex?
David Narrow is listed as CEO at Sonavex.
Where is Sonavex headquartered?
Sonavex is based in Baltimore, Maryland, United States.
How many employees does Sonavex have?
Sonavex is in the 1-10 employee band.
When was Sonavex founded?
Sonavex was founded in 2013.
How does Sonavex's funding compare to other Biotechnology startups?
Sonavex's latest round of $3.1M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Sonavex Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sonavex is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.